Aerpio Pharmaceuticals, Inc.
METHODS OF TREATING INTRAOCULAR PRESSURE WITH ACTIVATORS OF TIE-2
Last updated:
Abstract:
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for eye conditions associated with angiogenesis, for example, intraocular pressure, ocular hypertension, and glaucoma.
Status:
Application
Type:
Utility
Filling date:
15 Jan 2021
Issue date:
16 Dec 2021